VADT研究17年随访:强化血糖控制对晚期糖尿病患者眼部手术结局的影响
该研究基于退伍军人事务部糖尿病试验(VADT)17年随访数据,比较强化与标准血糖控制对晚期糖尿病患者累积眼部手术次数的影响。最终分析显示,强化控糖组在干预期及随访期间眼部手术次数仅轻度非显著增加;但调整血管标志物后,强化控糖与眼部手术增多的关联更为明显,提示强化控糖对需手术的眼部事件可能无保护作用。
要点
- 强化控糖未显著减少晚期糖尿病患者眼部手术次数。
- 调整血管标志物后,强化控糖组眼部手术增多趋势更明显。
- 强化控糖对需手术的糖尿病眼病事件可能无保护作用。
核心结论
- 在晚期糖尿病患者中,强化血糖控制对糖尿病视网膜病变相关手术或白内障手术等眼部手术结局未显示显著获益,调整血管标志物后甚至呈现手术次数增多的趋势。
研究设计与样本
- 研究比较VADT中强化血糖控制与标准血糖控制对累积眼部手术次数的影响,分析涵盖干预期(2000-2008,中位随访5.6年)、中期随访(2000-2013)及完整17年随访(2000-2017)。
- 采用两个模型分析数据:模型I纳入总胆固醇、HDL胆固醇、LDL胆固醇、甘油三酯、收缩压、舒张压和BMI;模型II在此基础上增加年龄和原试验基线糖尿病视网膜病变严重程度评分。
主要发现
- 最终分析显示,在三个研究期间,强化控糖组眼部手术次数及视网膜或视网膜联合白内障手术次数呈轻度但非显著增加。
- 调整部分已知血管标志物后,强化控糖组眼部手术次数增加的趋势更为明显。
临床怎么用
- 对于晚期糖尿病患者,强化血糖控制不应被视为减少眼部手术风险的可靠策略。
- 临床决策需综合评估晚期糖尿病患者的眼部手术风险,而非仅依赖强化控糖。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The objective of this study was to assess the long-term role of intensive glycemic control (INT) compared with standard glycemic control in accumulated eye procedures in patients with advanced diabetes. RESEARCH DESIGN AND METHODS: We compared the effect of treatment assignment on the accumulated number of eye procedures during the intervention period of the Veteran Affairs Diabetes Trial (VADT) (2000-2008) (median follow-up 5.6 years), the interim VADT follow-up study (2000-2013), and the full 17 years of VADT follow-up (2000-2017). We further analyzed data using various cardiovascular markers in two models. Model I included total cholesterol, HDL cholesterol, LDL cholesterol, triglycerides, systolic and diastolic blood pressure, and BMI. Model II included these covariates plus age and diabetic retinopathy (DR) severity score at baseline of the original trial. RESULTS: The final analysis of the data showed a mild but nonsignificant increase in number of procedures and in retinal or retinal plus cataract surgery during the three periods of the study. CONCLUSIONS: We found no significant benefit of INT during the original trial period in eye-related procedures, such as various procedures for DR, or during the 17 years of follow-up in cataract surgery. However, after adjusting data for some known vascular markers, the increase in the number of eye procedures with INT becomes more prevalent. This finding indicates that INT might not have a protective role in events requiring surgery in individuals with advanced diabetes.
引用
- Azad N, Agrawal L, Bahn G, et al. Eye Outcomes in Veteran Affairs Diabetes Trial (VADT) After 17 Years. Diabetes Care. 2021. PMID: 34187839. doi:10.2337/dc20-2882
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。